Ascent Wealth Partners, LLC Charles River Laboratories International, Inc. Transaction History

Ascent Wealth Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$126.05 - $152.76 $791,467 - $959,180	-6,279 Closed	0 $0
Q3 2019 Oct 22, 2019	BUY	$125.07 - $143.67 $25,014 - $28,733	200 Added 3.29%	6,279 $831,000
Q2 2019 Jul 30, 2019	BUY	$123.4 - $148.55 $32,084 - $38,623	260 Added 4.47%	6,079 $863,000
Q1 2019 May 13, 2019	BUY	$104.82 - $146.73 $47,273 - $66,175	451 Added 8.4%	5,819 $845,000
Q4 2018 Feb 13, 2019	SELL	$105.09 - $137.23 $4,203 - $5,489	-40 Reduced 0.74%	5,368 $608,000
Q3 2018 Aug 21, 2019	BUY	$112.11 - $134.54 $12,444 - $14,933	111 Added 2.1%	5,408 $728,000
Q2 2018 Aug 21, 2019	BUY	$102.37 - $117.25 $2,968 - $3,400	29 Added 0.55%	5,297 $594,000
Q1 2018 Aug 21, 2019	BUY	$98.19 - $115.2 $2,945 - $3,456	30 Added 0.57%	5,268 $562,000
Q4 2017 Aug 21, 2019	BUY	$100.43 - $118.09 $803 - $944	8 Added 0.15%	5,238 $573,000
Q3 2017 Aug 21, 2019	BUY	$96.72 - $109.26 $15,475 - $17,481	160 Added 3.16%	5,230 $565,000
Q2 2017 Aug 21, 2019	SELL	N/A	-5 Reduced 0.1%	5,070 $513,000
Q1 2017 Aug 21, 2019	BUY	N/A	25 Added 0.5%	5,075 $456,000
Q4 2016 Aug 21, 2019	BUY	N/A	5,050	5,050 $385,000

692

52M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.22B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Ascent Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ascent Wealth Partners, LLC with notifications on news.